Shares of CRISPR Therapeutics plunged dramatically Wednesday after the U.S. Food and Drug Administration (FDA) placed a clinical hold on a planned sickle cell disease treatment the company was in … Continue Reading FDA Chains Clinical Hold on CRISPR/ Vertex Sickle Cell Disease IND
HIV-infected patients experience a dysfunction in a certain type of immune cell: the follicular helper T (Tfh) cell. A team of Japanese scientists have used CRISPR-cas9 to destroy the … Continue Reading CRISPR Offers Hope of “Functional Cures” for HIV
Scientists have successfully developed a far easier way to manipulate different genes by using a common research model, baker’s yeast. CRISPR has before helped refine and accelerate the … Continue Reading CRISPR Used for High-Throughput Genetic Assessment
The Cas9 used for this experiment was catalytically inactive, known as dCas9, and lacked endonuclease potential. [Bill Oxford/Getty Images] Researchers from the Broad Institute invented a new … Continue Reading Caspex Marks a New Series of Opportunities for Genomics Fusion of CRISPR and APEX2 Stands to Bolster Genome Mapping Capabilities
A study at Karolinska Institutet in Sweden has revealed that CRISPR-Cas9 gene editing could favor mutations in the most common cancer-causing gene. What does it mean for the first CRISPR … Continue Reading Scientists Warn CRISPR Therapy Could Cause Cancer as First Human Trials Take Place
Two papers published today in Nature Medicine are raising a new potential red flag with CRISPR-Cas9 gene editing: Human cells that are successfully edited in the lab may have a … Continue Reading CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
CRISPR Therapeutics is using its proprietary CRISPR-Cas9 gene editing platform to develop transformative medicines. In this image, the Cas9 nuclease (whitish form) is being directed by a single-guide RNA (yellowish … Continue Reading Supplement: CRISPR Enters the Clinic Using CRISPR-Altered Cells to Fight Disease
Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease, will trigger cancer, two studies published on Monday warn — a potential game-changer for … Continue Reading A serious new hurdle for CRISPR: Edited cells might cause cancer, find two studies
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state to yield induced pluripotent stem cells (iPSCs), this was supposed to herald a revolution in … Continue Reading Regenerating the Body With Stem Cells – Hype or Hope?
The emergence of CRISPR/Cas9 technologies has enabled almost unlimited gene editing opportunities. Not only could it be used as a therapeutic tool, the genome editing tool could kickstart a revolution … Continue Reading CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?
CRISPR-Cas9 has taken the world by storm in just a few years with the promise of making genome editing much easier and faster than ever before. But how does this … Continue Reading A Review of CRISPR-Cas9: How is the Gene Editing Tool Changing the World?
HIV research has come a long way since the disease was discovered in the 1980’s. Antiretroviral therapy was a major milestone that has changed the lives of millions, but the … Continue Reading An HIV Cure by 2020? A Review of the Future of HIV Therapy